Rational design of a protein that binds integrin α(v)β(3) outside the ligand binding site

Integrin α(v)β(3) expression is altered in various diseases and has been proposed as a drug target. Here we use a rational design approach to develop a therapeutic protein, which we call ProAgio, that binds to integrin α(v)β(3) outside the classical ligand-binding site. We show ProAgio induces apopt...

Descripción completa

Detalles Bibliográficos
Autores principales: Turaga, Ravi Chakra, Yin, Lu, Yang, Jenny J., Lee, Hsiauwei, Ivanov, Ivaylo, Yan, Chunli, Yang, Hua, Grossniklaus, Hans E., Wang, Siming, Ma, Cheng, Sun, Li, Liu, Zhi-Ren
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4895024/
https://www.ncbi.nlm.nih.gov/pubmed/27241473
http://dx.doi.org/10.1038/ncomms11675

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4895024/
https://www.ncbi.nlm.nih.gov/pubmed/27241473
http://dx.doi.org/10.1038/ncomms11675

Ejemplares similares